People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JenaValve Technology Inc | — | Software / Tech | Series D+ | $328.5M | $2.2B | 2010 |
| CARISMA Therapeutics Inc. | — | Biotechnology | Series C | $95.0M | $1.3B | 2018 |
Regina Hodits at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Regina Hodits on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 1 | 18 |
| Robert Mitchell | 1 | 9 |
| Briggs Morrison | 1 | 8 |
| Andrew Hack | 1 | 5 |
| Quan Zhou | 1 | 5 |
| Bruce Peacock | 1 | 5 |
| Michael Heffernan | 1 | 5 |
| Margarita Chavez | 1 | 4 |
| Michael Poisel | 1 | 4 |
| Eran Nadav | 1 | 4 |
| Steven Kelly | 1 | 4 |
| Kenneth MacLeod | 1 | 3 |
| Chidozie Ugwumba | 1 | 3 |
| Jan Pensaert | 1 | 3 |
| Rudi Marien | 1 | 3 |
| Raymond Cohen | 1 | 2 |
| Ouyang Xiangyu | 1 | 2 |
| Peter Wulff | 1 | 2 |
| Jose Calle Gordo | 1 | 2 |
| Olivier Litzka | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.